Browsing by Title :
Showing results 11101 to 11120 of 17605
| Pub Year | | Title | Author(s) |
| 2019 | | Perturbation of MLKL-mediated endosomal trafficking enhances TRAIL signal to increase cancer cell death | 박세연 |
| 2014 | | Perturbation of NCOA6 leads to dilated cardiomyopathy. | 박찬배 |
| 2005 | | Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. | 김승업 |
| 2019 | | Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY) | 강석윤 |
| - | | Pharmaceutical complex formulations for treating neurodegenerative diseases | 임태성, 최문희, 홍지만 |
| 2016 | | PHARMACEUTICAL COMPOSITION COMPRISING CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONIST AND GINKGO BILOBA EXTRACT FOR TREATING OR PREVENTING SENSORINEURAL HEARING LOSS | 김연주, 박상면, 박정섭, 정연훈 |
| 2019 | | Pharmaceutical composition comprising extract of Cleyera japonica or fermented extract of Cleyera japonica for preventing or treating of respiratory diseases | 김미영, 정이숙 |
| - | | PHARMACEUTICAL COMPOSITION COMPRISING METHYLENE BLUE FOR TREATING OR PREVENTING SENSORINEURAL HEARING LOSS | 박상면, 박정섭 |
| 2016 | | Pharmaceutical composition comprising RIP3-MLKL pathway blocker for preventing or treating of skin cell necrosis disease | 구기방, 김유선 |
| - | | Pharmaceutical composition for antithrombotic comprising cilostazol and nitric oxide precursor | 홍지만 |
| 2017 | | Pharmaceutical composition for enhancing anticancer efficacy of 2-deoxyglucose comprising T-type calcium channel inhibitor | 윤준기, 이수진 |
| - | | PHARMACEUTICAL COMPOSITION FOR ENHANCING EFFECT OF ANTI-CANCER TREATING | 허훈 |
| - | | PHARMACEUTICAL COMPOSITION FOR ENHANCING EFFECT OF ANTI-CANCER TREATING | 허훈 |
| 2022 | | Pharmaceutical composition for preventing or treating angiogenesis relating ocular diseases comprising inhibitors of MCT expression or activity | 이기황 |
| - | | Pharmaceutical composition for preventing or treating Behcet's disease or rheumatoid arthritis comprising peptides or mixture thereof | 손성향 |
| - | | Pharmaceutical composition for preventing or treating bladder cancer comprising inducer or activator of BTG2 and screening method thereof | 임인경 |
| - | | Pharmaceutical composition for preventing or treating glaucoma comprising Vitis vinifera pip extract | 안재홍 |
| 2016 | | Pharmaceutical composition for preventing or treating hearing loss comprising carbenoxolon or its pharmaceutically acceptable salts as effective compound | 김연주, 정연훈 |
| 2017 | | Pharmaceutical composition for preventing or treating miRNA-34a related diseases comprising inducer or activator of TIS21 and screening method thereof | 유민숙, 임인경 |
| 2022 | | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 강엽, 정익락, 최성이 |
